Literature DB >> 25964258

Menthol Enhances the Desensitization of Human α3β4 Nicotinic Acetylcholine Receptors.

Hoai T Ton1, Amanda E Smart1, Brittany L Aguilar1, Thao T Olson1, Kenneth J Kellar2, Gerard P Ahern2.   

Abstract

The α3β4 nicotinic acetylcholine receptor (nAChR) subtype is widely expressed in the peripheral and central nervous systems, including in airway sensory nerves. The nAChR subtype transduces the irritant effects of nicotine in tobacco smoke and, in certain brain areas, may be involved in nicotine addiction and/or withdrawal. Menthol, a widely used additive in cigarettes, is a potential analgesic and/or counterirritant at sensory nerves and may also influence nicotine's actions in the brain. We examined menthol's effects on recombinant human α3β4 nAChRs and native nAChRs in mouse sensory neurons. Menthol markedly decreased nAChR activity as assessed by Ca(2+) imaging, (86)Rb(+) efflux, and voltage-clamp measurements. Coapplication of menthol with acetylcholine or nicotine increased desensitization, demonstrated by an increase in the rate and magnitude of the current decay and a reduction of the current integral. These effects increased with agonist concentration. Pretreatment with menthol followed by its washout did not affect agonist-induced desensitization, suggesting that menthol must be present during the application of agonist to augment desensitization. Notably, menthol acted in a voltage-independent manner and reduced the mean open time of single channels without affecting their conductance, arguing against a simple channel-blocking effect. Further, menthol slowed or prevented the recovery of nAChRs from desensitization, indicating that it probably stabilizes a desensitized state. Moreover, menthol at concentrations up to 1 mM did not compete for the orthosteric nAChR binding site labeled by [(3)H]epibatidine. Taken together, these data indicate that menthol promotes desensitization of α3β4 nAChRs by an allosteric action.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25964258      PMCID: PMC4518085          DOI: 10.1124/mol.115.098285

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  42 in total

1.  A study of the desensitization produced by acetylcholine at the motor end-plate.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

2.  Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes.

Authors:  F Olale; V Gerzanich; A Kuryatov; F Wang; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

3.  Potentiation and inhibition of subtypes of neuronal nicotinic acetylcholine receptors by Pb2+.

Authors:  R Zwart; R G Van Kleef; J M Milikan; M Oortgiesen; H P Vijverberg
Journal:  Eur J Pharmacol       Date:  1995-11-30       Impact factor: 4.432

4.  Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine.

Authors:  C P Fenster; M F Rains; B Noerager; M W Quick; R A Lester
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

5.  Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of alpha3beta4, a novel subtype in the mammalian nervous system.

Authors:  C M Flores; R M DeCamp; S Kilo; S W Rogers; K M Hargreaves
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

6.  Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation.

Authors:  Louis S Premkumar; Manish Raisinghani; Sandeep C Pingle; Cheng Long; Fátima Pimentel
Journal:  J Neurosci       Date:  2005-12-07       Impact factor: 6.167

7.  Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes.

Authors:  L Ke; R J Lukas
Journal:  J Neurochem       Date:  1996-09       Impact factor: 5.372

8.  Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.

Authors:  Ramiro Salas; Fredalina Pieri; Mariella De Biasi
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

9.  Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.

Authors:  Y Xiao; E L Meyer; J M Thompson; A Surin; J Wroblewski; K J Kellar
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

10.  Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors.

Authors:  A D Maus; E F Pereira; P I Karachunski; R M Horton; D Navaneetham; K Macklin; W S Cortes; E X Albuquerque; B M Conti-Fine
Journal:  Mol Pharmacol       Date:  1998-11       Impact factor: 4.436

View more
  23 in total

1.  Chronic Menthol Does Not Change Stoichiometry or Functional Plasma Membrane Levels of Mouse α3β4-Containing Nicotinic Acetylcholine Receptors.

Authors:  Selvan Bavan; Charlene H Kim; Brandon J Henderson; Henry A Lester
Journal:  Mol Pharmacol       Date:  2019-01-22       Impact factor: 4.436

2.  Effects of menthol and its interaction with nicotine-conditioned cue on nicotine-seeking behavior in rats.

Authors:  Erin Harrison; Lisa Biswas; Ramachandram Avusula; Meiyu Zhang; Yongzhen Gong; Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2017-09-16       Impact factor: 4.530

3.  Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes.

Authors:  Suchitra Krishnan-Sarin; Barry G Green; Grace Kong; Dana A Cavallo; Peter Jatlow; Ralitza Gueorguieva; Eugenia Buta; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

4.  Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling.

Authors:  Robert J Wickham; Eric J Nunes; Shannon Hughley; Phillip Silva; Sofia N Walton; Jinwoo Park; Nii A Addy
Journal:  Neuropharmacology       Date:  2017-09-21       Impact factor: 5.250

5.  Impact of menthol on nicotine intake and preference in mice: Concentration, sex, and age differences.

Authors:  Deniz Bagdas; Asti Jackson; Moriah Carper; Rita Yu-Tzu Chen; Lois S Akinola; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-08-20       Impact factor: 5.250

6.  Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers.

Authors:  Gerald W Valentine; Elise E DeVito; Peter I Jatlow; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  J Psychopharmacol       Date:  2018-05-23       Impact factor: 4.153

7.  Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Authors:  Brandon J Henderson; Teagan R Wall; Beverley M Henley; Charlene H Kim; Weston A Nichols; Ruin Moaddel; Cheng Xiao; Henry A Lester
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

8.  Effect of menthol on nicotine intake and relapse vulnerability in a rat model of concurrent intravenous menthol/nicotine self-administration.

Authors:  Tanseli Nesil; Syeda Narmeen; Anousheh Bakhti-Suroosh; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-11-27       Impact factor: 4.530

9.  Effect of Menthol-preferring Status on Response to Intravenous Nicotine.

Authors:  Elise E DeVito; Gerald W Valentine; Aryeh I Herman; Kevin P Jensen; Mehmet Sofuoglu
Journal:  Tob Regul Sci       Date:  2016-10

10.  Menthol Binding to the Human α4β2 Nicotinic Acetylcholine Receptor Facilitated by Its Strong Partitioning in the Membrane.

Authors:  Rezvan Shahoei; Emad Tajkhorshid
Journal:  J Phys Chem B       Date:  2020-03-02       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.